Description: Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
Home Page: www.predilife.com
39, Rue Camille Desmoulins
Villejuif,
94805
France
Phone:
33 09 72 22 67 08
Officers
| Name | Title |
|---|---|
| Mr. Stephane Ragusa | Founder, Pres, CEO & Chairman |
| Mr. Émilien Gauthier | Chief Technical Officer and R&D Director |
| Marion Renelier | Legal Director |
| Elise Tronel | Sales Director |
| Anne Kerzan | Chief Marketing Officer |
Exchange: PA
Country: FR
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 34.2918 |
| Price-to-Sales TTM: | 78.8096 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 14 |